JW Holdings products

Self-microemulsifying drug delivery system (SMEDDS) is a solubilization technology for improving bioavailability of poorly soluble drugs. By combining surfactant and co-surfactant with a poorly soluble drug, this technology improves the bioavailability of the drug by forming fine emulsion droplets upon dilution with physiological fluid after administration. This proprietary technology utilized SMEDDS technology to solubilize the poorly soluble drug, and further adsorbed the mixture to the solid carriers in order to prepare them into tablets, which enabled solidification of soft capsules into tablets and overcome the shortcomings of temperature-sensitive soft capsules and increase the convenience of administration.

CTP (Cytoplasmic Transduction Peptide) Technology is effective drug delivery system that ensure the cytoplasmic delivery of the CTP-fused polymeric biomolecules.